Exciting news! ATAGI just unveiled guidelines for the latest Monovalent Omicron XBB.1.5 vaccines, now accessible in Australia. #PROPHEC19#COVID19 https://t.co/dF5x95D338
15th Nov is #WorldCOPDDay. The #PROPHEC19 study is advancing our understanding of immune responses to COVID-19 vaccinations in people with underlying health conditions, like COPD, to aid in shaping the future care and vaccine strategies. #COPD#PROPHECYStudy
There is a 'double-whammy' positive effect to the monovalent vaccine that is available in many other jurisdictions (in the US for all >6 months of age) - I spoke about that & other issues in this piece from @Flinty_01
https://t.co/mMHwMKgi1O
Twitter https://t.co/b0aC6nFnWP
🚨 Update on COVID-19 Vaccines in Australia 🇦🇺: The TGA approved Pfizer and Moderna's updated vaccines targeting the XBB.1.5 variant. While available in the US and EU, ATAGI is assessing their use in Aus. Stay tuned for updates on vaccine availability! #COVID19#PROPHEC19💉
New preprint study on #COVID19 boosters! #PROPHEC19 researchers found that a 3rd mRNA vaccine dose enhances IgG4 response and Omicron recognition in memory B cells. #ScienceTwitter#Vaccination#Omicron https://t.co/sSEOXClrEN
@BurnetInstitute is searching for a Research Associate or Officer to join their Antiviral Immunity team. Research will focus on COVID-19 vaccines and the #PROPHEC19 study. 🦠🧪🔬#ResearchOpportunity
📢 The Antiviral Immunity team @BurnetInstitute is recruiting! Are you interested in applying your immunology skills to improving patients outcomes in the clinic? We're looking for a RA or RO to contribute to our COVID-19 vaccine & other virus studies 👇
https://t.co/HhiLmSjGcw
COVID is still a formidable foe and we can't rely on vaccines alone. The advice from @profmiketoole@majumdar_suman and @hdrummer1 is to avoid (re)infection, breathe clean indoor air, wear high quality masks and get tested to access antivirals if eligible. https://t.co/Y0guxUCDkA
🌟 On #RUOKDay, the #PROPHEC19 study emphasises the vital role of mental well-being. Let's reach out to those around us with a heartfelt "How are you feeling today?" ❤️ Your genuine concern can make a world of difference. @ruokday@MonashHealth@AlfredHealth@MCRI_for_kids
🤝 Grateful on #InternationalDayofCharity, for our study participants in the #PROPHEC19 study. Your volunteered time and samples are driving important research forward. Let's continue to make a positive impact together. ❤️🌍 #CharityDay#GiveBack
❤️🩹On #PKDAwarenessDay, let's illuminate the challenges faced by PKD warriors. While the #PROPHEC19 study focuses on CKD and kidney transplant cohorts, our research aims to improve vaccine guidelines for a better future for those with kidney-related conditions #KidneyHealth